Literature DB >> 8290425

Guillain-Barré syndrome in a patient with chronic lymphocytic leukaemia.

M Jackson.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8290425      PMCID: PMC2399951          DOI: 10.1136/pgmj.69.816.832-a

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

2.  [Landry syndrome in a case of leukemia].

Authors:  A M LORENTZ DE HAAS
Journal:  Rev Neurol (Paris)       Date:  1951       Impact factor: 2.607

3.  Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies.

Authors:  R P Lisak; M Mitchell; B Zweiman; E Orrechio; A K Asbury
Journal:  Ann Neurol       Date:  1977-01       Impact factor: 10.422

4.  Guillain-Barré syndrome associated with chronic lymphatic leukaemia.

Authors:  R L Powles; J S Malpas
Journal:  Br Med J       Date:  1967-07-29

Review 5.  Chronic lymphocytic leukemia: new insights into biology and therapy.

Authors:  K A Foon; K R Rai; R P Gale
Journal:  Ann Intern Med       Date:  1990-10-01       Impact factor: 25.391

Review 6.  The impact of Hodgkin's disease on the immune system.

Authors:  D J Slivnick; T M Ellis; J F Nawrocki; R I Fisher
Journal:  Semin Oncol       Date:  1990-12       Impact factor: 4.929

7.  Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis (Guillain-Barré syndrome).

Authors:  R A Hughes; S Aslan; I A Gray
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

8.  Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome.

Authors:  C L Koski; E Gratz; J Sutherland; R F Mayer
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.